{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T10:26:07Z","timestamp":1758709567244,"version":"3.44.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.xphs.2021.05.017","type":"journal-article","created":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T03:01:04Z","timestamp":1622602864000},"page":"3410-3417","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Identification of an Oxidizing Leachable from a Clinical Syringe Rubber Stopper"],"prefix":"10.1016","volume":"110","author":[{"given":"Ariane","family":"Schr\u00f6ter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonja","family":"Peter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2427-6795","authenticated-orcid":false,"given":"Hanns-Christian","family":"Mahler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Zerr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9323-7079","authenticated-orcid":false,"given":"Ombeline","family":"Danton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Chalus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2669-5405","authenticated-orcid":false,"given":"Atanas V.","family":"Koulov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg","family":"Huwyler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Jahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.xphs.2021.05.017_bib0001","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.tibtech.2012.10.004","article-title":"Single-use disposable technologies for biopharmaceutical manufacturing","volume":"31","author":"Shukla","year":"2013","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.xphs.2021.05.017_bib0002","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.fbp.2013.12.002","article-title":"Single-use in the biopharmaceutical industry: a review of current technology impact, challenges and limitations","volume":"93","author":"Lopes","year":"2015","journal-title":"Food Bioprod Process"},{"key":"10.1016\/j.xphs.2021.05.017_bib0003","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.csbj.2016.06.007","article-title":"A single-use strategy to enable manufacturing of affordable biologics","volume":"14","author":"Jacquemart","year":"2016","journal-title":"Comput Struct Biotechnol J"},{"year":"2009","series-title":"Plastics additives handbook","author":"Zweifel","key":"10.1016\/j.xphs.2021.05.017_bib0004"},{"issue":"5","key":"10.1016\/j.xphs.2021.05.017_bib0005","doi-asserted-by":"crossref","first-page":"407","DOI":"10.5731\/pdajpst.2014.00995","article-title":"A compilation of safety impact information for extractables associated with materials used in pharmaceutical packaging, delivery, administration, and manufacturing systems","volume":"68","author":"Jenke","year":"2014","journal-title":"PDA J Pharm Sci Technol"},{"issue":"5","key":"10.1016\/j.xphs.2021.05.017_bib0006","doi-asserted-by":"crossref","first-page":"590","DOI":"10.5731\/pdajpst.2015.01073","article-title":"Creating a holistic extractables and leachables (E&L) program for biotechnology products","volume":"69","author":"Li","year":"2015","journal-title":"PDA J Pharm Sci Technol"},{"issue":"5","key":"10.1016\/j.xphs.2021.05.017_bib0007","doi-asserted-by":"crossref","first-page":"430","DOI":"10.5731\/pdajpst.2013.00936","article-title":"The Product Quality Research Institute (PQRI) leachables and extractables working group initiatives for parenteral and ophthalmic drug product (PODP)","volume":"67","author":"Paskiet","year":"2013","journal-title":"PDA J Pharm Sci Technol"},{"issue":"5","key":"10.1016\/j.xphs.2021.05.017_bib0008","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1002\/jps.23931","article-title":"Impact of residual impurities and contaminants on protein stability","volume":"103","author":"Wang","year":"2014","journal-title":"J Pharmaceut Sci"},{"issue":"11","key":"10.1016\/j.xphs.2021.05.017_bib0009","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1007\/s11095-010-0193-8","article-title":"Leachables from saline-containing IV bags can alter therapeutic protein properties","volume":"27","author":"Chang","year":"2010","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2021.05.017_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2019.105069","article-title":"Quantitative characterization of leachables sinks in biopharmaceutical downstream processing","volume":"143","author":"Paudel","year":"2020","journal-title":"Eur J Pharmaceut Sci"},{"key":"10.1016\/j.xphs.2021.05.017_bib0011","unstructured":"United States Food and Drug Administration FDA. 21 CFR Sec. 211.65, Equipment construction. Revised as of April 1, 2019."},{"key":"10.1016\/j.xphs.2021.05.017_bib0012","unstructured":"United States Food and Drug Administration FDA. 21 CFR Sec. 211.94, Drug product containers and closures. Revised as of April 1, 2020."},{"issue":"4","key":"10.1016\/j.xphs.2021.05.017_bib0013","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/app.12263","article-title":"Use of binary ethanol\/water model solutions to mimic the interaction between a plastic material and pharmaceutical formulations","volume":"89","author":"Jenke","year":"2003","journal-title":"J Appl Polymer Sci"},{"issue":"8","key":"10.1016\/j.xphs.2021.05.017_bib0014","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s11095-018-2430-5","article-title":"Considerations for the use of polysorbates in biopharmaceuticals","volume":"35","author":"Jones","year":"2018","journal-title":"Pharm Res"},{"issue":"Suppl_3","key":"10.1016\/j.xphs.2021.05.017_bib0015","doi-asserted-by":"crossref","first-page":"iii33","DOI":"10.1093\/ndt\/gfh1072","article-title":"Epoetin-associated pure red cell aplasia in patients with chronic kidney disease: solving the mystery","volume":"20","author":"Boven","year":"2005","journal-title":"Nephrol Dial Transpl"},{"key":"10.1016\/j.xphs.2021.05.017_bib0016","first-page":"86","article-title":"Technical investigations into the cause of the increased incidence of antibody-mediated pure red cell aplasia associated with EPREX","volume":"5","author":"Sharma","year":"2004","journal-title":"Eur J Hospital Pharm"},{"issue":"10","key":"10.1016\/j.xphs.2021.05.017_bib0017","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1002\/jps.21672","article-title":"Evaluation of the immuno-stimulatory potential of stopper extractables and leachables by using dendritic cells as readout","volume":"98","author":"Mueller","year":"2009","journal-title":"J Pharmaceut Sci"},{"issue":"4","key":"10.1016\/j.xphs.2021.05.017_bib0018","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.intimp.2005.10.001","article-title":"An in vivo model to assess factors that may stimulate the generation of an immune reaction to erythropoietin","volume":"6","author":"Ryan","year":"2006","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.xphs.2021.05.017_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113602","article-title":"Identification of extractables by liquid chromatography-high resolution mass spectrometry: a case study to understand the extraction profile of different disposable syringes","volume":"191","author":"Kurmi","year":"2020","journal-title":"J Pharmaceut Biomed Anal"},{"key":"10.1016\/j.xphs.2021.05.017_bib0020","unstructured":"European Medicines Agency (EMEA). Committee for medicinal products for human use CHMP. ICH guideline Q8 (R2) on pharmaceutical development. Revised as of June 22, 2017."},{"year":"2014","series-title":"IARC monographs <106>trichloroethylene, tetrachloroethylene, and some other chlorinated agents","key":"10.1016\/j.xphs.2021.05.017_bib0021"},{"issue":"2","key":"10.1016\/j.xphs.2021.05.017_bib0022","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1006\/abio.2000.4696","article-title":"A critical evaluation of the effect of sorbitol on the ferric\u2013xylenol orange hydroperoxide assay","volume":"284","author":"Gay","year":"2000","journal-title":"Anal Biochem"},{"issue":"3","key":"10.1016\/j.xphs.2021.05.017_bib0023","doi-asserted-by":"crossref","first-page":"523","DOI":"10.18388\/abp.2009_2489","article-title":"Determination of hydroperoxides in aqueous solutions containing surfactants by the ferrous oxidation-xylenol orange method","volume":"56","author":"Meisner","year":"2009","journal-title":"Acta Biochim Pol"},{"year":"2020","series-title":"Best practice guide for extractables testing of polymeric single-use components used in biopharmaceutical manufacturing","key":"10.1016\/j.xphs.2021.05.017_bib0024"},{"issue":"Pt A","key":"10.1016\/j.xphs.2021.05.017_bib0025","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ejpb.2015.09.016","article-title":"Key interactions of surfactants in therapeutic protein formulations: a review","volume":"97","author":"Khan","year":"2015","journal-title":"Eur J Pharm Biopharm"},{"year":"2014","series-title":"Guidance for industry - immunogenicity assessement for therapeutic protein products","key":"10.1016\/j.xphs.2021.05.017_bib0026"},{"issue":"10","key":"10.1016\/j.xphs.2021.05.017_bib0027","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1002\/jps.22597","article-title":"Effects of surfaces and leachables on the stability of biopharmaceuticals","volume":"100","author":"Bee","year":"2011","journal-title":"J Pharmaceut Sci"},{"issue":"5","key":"10.1016\/j.xphs.2021.05.017_bib0028","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1007\/s11095-011-0385-x","article-title":"The degradation of polysorbates 20 and 80 and its potential impact on the stability of biotherapeutics","volume":"28","author":"Kishore","year":"2011","journal-title":"Pharm Res"},{"issue":"6","key":"10.1016\/j.xphs.2021.05.017_bib0029","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1016\/j.xphs.2020.03.003","article-title":"Stabilizing polysorbate 20 and 80 against oxidative degradation","volume":"109","author":"Schmidt","year":"2020","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2021.05.017_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.xphs.2021.01.027","article-title":"4-Hydroxynonenal is an oxidative degradation product of polysorbate 80","author":"Schr\u00f6ter","year":"2021","journal-title":"J Pharmaceut Sci"},{"issue":"1","key":"10.1016\/j.xphs.2021.05.017_bib0031","doi-asserted-by":"crossref","first-page":"12","DOI":"10.5731\/pdajpst.2012.00803","article-title":"Interactions between therapeutic proteins and acrylic acid leachable","volume":"66","author":"Liu","year":"2012","journal-title":"PDA J Pharm Sci Technol"},{"key":"10.1016\/j.xphs.2021.05.017_bib0032","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1016\/j.xphs.2021.01.027","article-title":"4-Hydroxynonenal \u2013 a novel leachable from clinically used administration materials","volume":"110","author":"Schr\u00f6ter","year":"2021","journal-title":"J Pharm Sci"},{"issue":"25","key":"10.1016\/j.xphs.2021.05.017_bib0033","doi-asserted-by":"crossref","first-page":"7848","DOI":"10.1021\/bi034431g","article-title":"Mutational spectrum and genotoxicity of the major lipid peroxidation product, trans-4-hydroxy-2-nonenal, induced DNA adducts in nucleotide excision repair-proficient and -deficient human cells","volume":"42","author":"Feng","year":"2003","journal-title":"Biochemistry"},{"issue":"12","key":"10.1016\/j.xphs.2021.05.017_bib0034","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1038\/cdd.2013.138","article-title":"Cell death and diseases related to oxidative stress:4-hydroxynonenal (HNE) in the balance","volume":"20","author":"Dalleau","year":"2013","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.xphs.2021.05.017_bib0035","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.tifs.2019.12.011","article-title":"4-Hydroxy-2-nonenal in food products: a review of the toxicity, occurrence, mitigation strategies and analysis methods","volume":"96","author":"Liao","year":"2020","journal-title":"Trends Food Sci Technol"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354921002823?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354921002823?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:35:32Z","timestamp":1758360932000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354921002823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S0022354921002823"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2021.05.017","relation":{},"ISSN":["0022-3549"],"issn-type":[{"type":"print","value":"0022-3549"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of an Oxidizing Leachable from a Clinical Syringe Rubber Stopper","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2021.05.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Pharmacists Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}